15/02/2024
StemLife is a subsidiary of Cordlife Group Limited, which operates Asia’s largest network of stem cell banks, trusted by 600,000 parents. As a group, our journey began in 2001, and since then, we’ve helped clients use their stored cord blood at 18 esteemed healthcare institutions in 9 countries, enabling them to regain their health.
66% of the cord blood release we’ve facilitated has been used for the child whose cord blood was initially preserved, while the remaining 34% has been a lifeline to their siblings. Among our clients, we’ve witnessed the most frequent application of cord blood in cases related to cerebral palsy, autism, blood disorders, and various forms of cancer.
Cord blood is undeniably one of life’s most precious gifts and a source of immense potential. We envision a future where cord blood takes centre stage in personalised treatments and transformative cell therapies. StemLife is here to stand by you, assisting in preserving your child’s cord blood and aligning the forces of nature with the prospects of modern medicine.
To learn more about StemLife’s successful cord blood releases, visit: https://www.stemlife.com/en/stemlife/cord-blood-cordlife-transplant-cases
Schedule an appointment with our friendly consultant today!
